Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Atrial Fibrillation
Interventions
DRUG

Adenosine arm

In the adenosine arm, 25 patients will be randomized to received 2 doses of adenosine 12 mg IV, 5 minutes apart after pulmonary vein isolation. During this time, will monitor for pulmonary vein reconnection, second dose of adenosine will be given only if no reconnection after initial dose. In the observation arm, 25 patients will be randomized to 10 minute period of observation for pulmonary vein reconnection after documentation of pulmonary vein isolation.

Trial Locations (1)

53226

Froedtert Hospital, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT01590875 - Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation | Biotech Hunter | Biotech Hunter